Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Lung Cancer
76%
Venous Thromboembolism
57%
Retina Vein Occlusion
33%
Malignant Neoplasm
22%
Thromboembolism
19%
Cardiovascular Disease
19%
Antiplatelet
19%
Nervous System Injury
19%
Brain Hemorrhage
19%
Eye Disease
19%
Cataract
19%
Patient Registry
19%
Non Small Cell Lung Cancer
17%
Glaucoma
14%
Peripheral Occlusive Artery Disease
9%
Prevalence
9%
Chemotherapy
9%
Immunotherapy
9%
Cancer Staging
8%
Congestive Heart Failure
7%
Diseases
6%
Medicine and Dentistry
Cohort Analysis
78%
Lung Cancer
76%
Venous Thromboembolism
57%
Thromboprophylaxis
23%
Cancer Surgery
19%
Thromboembolism
19%
Antiplatelet
19%
Cerebral Hemorrhage
19%
Nervous System Injury
19%
Health Care
19%
Cancer Treatment
19%
Lifespan
19%
Arteriosclerosis Obliterans
19%
Non Small Cell Lung Cancer
17%
Computer Assisted Tomography
14%
Cancer Therapy
11%
Targeted Therapy
9%
Immunotherapy
9%
Cancer Staging
8%
Malignant Neoplasm
7%
Prevalence
7%
Thorax Surgery
6%
Chemotherapy
6%
Shared Decision Making
6%
